Literature DB >> 23800545

The papillomavirus major capsid protein L1.

Christopher B Buck1, Patricia M Day, Benes L Trus.   

Abstract

The elegant icosahedral surface of the papillomavirus virion is formed by a single protein called L1. Recombinant L1 proteins can spontaneously self-assemble into a highly immunogenic structure that closely mimics the natural surface of native papillomavirus virions. This has served as the basis for two highly successful vaccines against cancer-causing human papillomaviruses (HPVs). During the viral life cycle, the capsid must undergo a variety of conformational changes, allowing key functions including the encapsidation of the ~8 kb viral genomic DNA, maturation into a more stable state to survive transit between hosts, mediating attachment to new host cells, and finally releasing the viral DNA into the newly infected host cell. This brief review focuses on conserved sequence and structural features that underlie the functions of this remarkable protein.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HPV; HPV16; L2; Maturation; Papillomaviridae; Virion

Mesh:

Substances:

Year:  2013        PMID: 23800545      PMCID: PMC3783536          DOI: 10.1016/j.virol.2013.05.038

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  69 in total

1.  Use of an in vivo animal model for assessing the role of integrin α(6)β(4) and syndecan-1 in early steps in papillomavirus infection.

Authors:  Hao-Shun Huang; Paul F Lambert
Journal:  Virology       Date:  2012-09-18       Impact factor: 3.616

2.  Taking the gritty approach.

Authors:  Andreas von Bubnoff
Journal:  IAVI Rep       Date:  2012 Nov-Dec

3.  Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.

Authors:  Katherine M Johnson; Rhonda C Kines; Jeffrey N Roberts; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

4.  Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids.

Authors:  Patricia M Day; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

5.  Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®).

Authors:  Troy J Kemp; Mahboobeh Safaeian; Allan Hildesheim; Yuanji Pan; Kerri J Penrose; Carolina Porras; John T Schiller; Douglas R Lowy; Rolando Herrero; Ligia A Pinto
Journal:  Vaccine       Date:  2012-10-31       Impact factor: 3.641

6.  SNX17 facilitates infection with diverse papillomavirus types.

Authors:  Martina Bergant; Lawrence Banks
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

Review 7.  Host-cell factors involved in papillomavirus entry.

Authors:  Luise Florin; Martin Sapp; Gilles A Spoden
Journal:  Med Microbiol Immunol       Date:  2012-09-13       Impact factor: 4.148

8.  Target cell cyclophilins facilitate human papillomavirus type 16 infection.

Authors:  Malgorzata Bienkowska-Haba; Hetalkumar D Patel; Martin Sapp
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

9.  Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs).

Authors:  Gilles Spoden; Kirsten Freitag; Matthias Husmann; Klaus Boller; Martin Sapp; Carsten Lambert; Luise Florin
Journal:  PLoS One       Date:  2008-10-02       Impact factor: 3.240

10.  Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1.

Authors:  John Lowe; Debasis Panda; Suzanne Rose; Ty Jensen; Willie A Hughes; For Yue Tso; Peter C Angeletti
Journal:  Virol J       Date:  2008-12-17       Impact factor: 4.099

View more
  65 in total

1.  Peptidic inhibitors for in vitro pentamer formation of human papillomavirus capsid protein l1.

Authors:  Ding-Yi Fu; Shi Jin; Dong-Dong Zheng; Xiao Zha; Yuqing Wu
Journal:  ACS Med Chem Lett       Date:  2015-02-25       Impact factor: 4.345

Review 2.  Human papillomavirus molecular biology.

Authors:  Mallory E Harden; Karl Munger
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-05       Impact factor: 5.657

3.  Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.

Authors:  Sara L Bissett; Anna Godi; Maxime J J Fleury; Antoine Touze; Clementina Cocuzza; Simon Beddows
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

4.  Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity.

Authors:  Sylvia L Ranjeva; Edward B Baskerville; Vanja Dukic; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano; Greg Dwyer; Sarah Cobey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-05       Impact factor: 11.205

5.  Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 6.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

7.  Concurrence of Iridovirus, Polyomavirus, and a Unique Member of a New Group of Fish Papillomaviruses in Lymphocystis Disease-Affected Gilthead Sea Bream.

Authors:  Alberto López-Bueno; Carla Mavian; Alejandro M Labella; Dolores Castro; Juan J Borrego; Antonio Alcami; Alí Alejo
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 8.  Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection.

Authors:  Omid Tavassoly; Farinaz Safavi; Iman Tavassoly
Journal:  Mol Pharmacol       Date:  2020-09-10       Impact factor: 4.436

9.  The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.

Authors:  Elena Wüstenhagen; Laura Hampe; Fatima Boukhallouk; Marc A Schneider; Gilles A Spoden; Inka Negwer; Kaloian Koynov; W Martin Kast; Luise Florin
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.

Authors:  Matthew P Bronnimann; Christine M Calton; Samantha F Chiquette; Shuaizhi Li; Mingfeng Lu; Janice A Chapman; Kristin N Bratton; Angela M Schlegel; Samuel K Campos
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.